Sinoway Industrial Co., Ltd.

Celecoxib 169590-42-5 Celecoxib 169590-42-5

Celecoxib 169590-42-5
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

  • NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

  • NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

Basic information of Celecoxib:

Name

Celecoxib

CAS NO.

169590-42-5

Molecular Formula

C17H14F3N3O2S

Molecular Weight

381.38

Grade Standard

Medicine grade  / 99% min / USP/ EP / GMP application / PMDA / DMF

Package Size

25kg/drum

Storage:

Keep in a well-closed container, protected from light and stored at a temperature of 2 to 8


Use of Celecoxib: 

Celecoxib is used to relieve the symptoms and signs of osteoarthritis, relieve the symptoms and signs of rheumatoid arthritis, and treat acute pain in adults.

The highest blood concentration was achieved approximately 3 hours after oral administration of a single dose of celecoxib. In the fasting state, when the dose of celecoxib is as high as 200mg twice daily, the highest blood concentration (Cmax) and the area under the curve (AUC) are roughly proportional to the dose; when the dose is increased, this proportional relationship Weaken (see food effects). At present, no studies have been conducted on absolute bioavailability. Steady-state plasma levels can be reached within 5 days after multiple doses.

COA of Celecoxib :


COA of Celecoxib

* Products under the patent are only for R&D use.

  • Tenofovir disoproxil fumarate 202138-50-9
    Basic information of Tenofovir disoproxil fumarateNameTenofovir disoproxil fumarateAlias(((((1-(6-aMino-9H-purin-9-yl)propan-2-yl)oxy)Methyl)phosphoryl)bis(oxy))bis(Methylene) diisopropyl dicarbonate ... Tenofovir disoproxil fumarate 202138-50-9
  • Dexamethasone 50-02-2
    Basic information:Product Name: DexamethasoneMolecular Formula : C22H29FO5Molecular Weight: 392.46CAS No.: 50-02-2Appearance: White crystalline powderSpecifications:USP38/BP2010/EP6Usages :It used for aut... Dexamethasone 50-02-2
  • Valnemulin Hydrochloride 133868-46-9
    Basic information of Valnemulin HydrochlorideNameValnemulin HydrochlorideAlias Valnemulin HCL;econorCAS NO.133868-46-9Molecular FormulaC31H53ClN2O5SMolecular Weight601.28Quality Standard96% min; GMPGr... Valnemulin Hydrochloride 133868-46-9
  • Galantamine 357-70-0
    Basic information of GalantamineNameGalantamineAliasGalantamine hydrobromCAS Number357-70-0Molecular FormulaC17H21NO3Molecular Weight287.35Quality StandardIn housePackage Size5kg/bag, 10kg/bag, accord... Galantamine 357-70-0

MORE_DETAIL Celecoxib 169590-42-5

Basic information of Celecoxib:

Name

Celecoxib

CAS NO.

169590-42-5

Molecular Formula

C17H14F3N3O2S

Molecular Weight

381.38

Grade Standard

Medicine grade  / 99% min / USP/ EP / GMP application / PMDA / DMF

Package Size

25kg/drum

Storage:

Keep in a well-closed container, protected from light and stored at a temperature of 2 to 8


Use of Celecoxib: 

Celecoxib is used to relieve the symptoms and signs of osteoarthritis, relieve the symptoms and signs of rheumatoid arthritis, and treat acute pain in adults.

The highest blood concentration was achieved approximately 3 hours after oral administration of a single dose of celecoxib. In the fasting state, when the dose of celecoxib is as high as 200mg twice daily, the highest blood concentration (Cmax) and the area under the curve (AUC) are roughly proportional to the dose; when the dose is increased, this proportional relationship Weaken (see food effects). At present, no studies have been conducted on absolute bioavailability. Steady-state plasma levels can be reached within 5 days after multiple doses.

COA of Celecoxib :


COA of Celecoxib

* Products under the patent are only for R&D use.
Leave a Message Email Us

We will contact you within 24 hours.

  • TEL:+86-0592-5853819
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China